Arrowhead Pharmaceuticals and Vivo Capital launch joint venture in China
CHINA –Arrowhead and Vivo Capital are forming Visirna Therapeutics to bring four of the...
Read More
Tag: Arrowhead pharmaceuticals
Pfizer backs out of vupanorsen development, hands back rights to partner Ionis
USA – Pfizer has terminated its collaboration with Ionis for the cholesterol-lowering therapy...
Read More
Arrowhead and GSK tie up to develop RNAi drug in a deal worth over US$1 billion
USA – Arrowhead Pharmaceuticals, a company aiming to develop drugs using RNA interference...
Read More
Denmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma
DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals...
Read More
LATEST DIGITAL MAGAZINE
